Array ( [0] => Applebot/0.1 [1] => facebookexternalhit/1.1 [2] => LinkedInBot/1.0 [3] => meta-externalagent/1.1 [4] => Amazonbot/0.1 [5] => BLEXBot/1.0 [6] => DotBot/1.2 [7] => Qwantbot/1.0_1997801 [8] => AhrefsBot/7.0 [9] => DataForSeoBot/1.0 [10] => MatchorySearch/1.3 [11] => WRTNBot/1.0 [12] => Sogou web spider/4.0 [13] => MojeekBot/0.11 [14] => Yeti/1.1 [15] => SeznamBot/4.0 [16] => SemrushBot-SI/0.97 [17] => MistralAI-User/1.0 [18] => Qwantbot/1.0 [19] => coccocbot-web/1.0 [20] => coccocbot-image/1.0 [21] => PlagAwareBot/3.2 [22] => Barkrowler/0.9 [23] => AwarioSmartBot/1.0 [24] => PetalBot [25] => archive.org_bot [26] => Iframely/1.3.1 [27] => LogRocket-AssetCacher [28] => Slackbot 1.0 [29] => node-fetch/1.0 [30] => MJ12bot/v1.4.8 [31] => MJ12bot/v2.0.0 [32] => Timpibot/0.9 [33] => AwarioBot/1.0 [34] => MJ12bot/v2.0.1 [35] => Qwantbot/1.0_2850318 [36] => SiteAuditBot/0.97 [37] => Scrapy/2.11.2 [38] => CCBot/2.0 [39] => MJ12bot/v2.0.2 [40] => Scrapy/2.13.3 [41] => WordPress/6.8.3 [42] => MJ12bot/v2.0.4 [43] => SemrushBot/7~bl [44] => Qwairy-Bot/1.0 [45] => Embedly/0.2 [46] => GeedoProductSearch [47] => SemrushBot [48] => vkShare [49] => inkrich [50] => Discordbot/2.0 [51] => IbouBot/1.0 [52] => trafilatura/1.6.3 [53] => AnsehnBot/1.0 [54] => WP-URLDetails/6.8.3 [55] => HubSpot Crawler [56] => ShapBot/0.1.0 [57] => udu/1.6.5 [58] => aiohttp/3.13.1 [59] => l9scan/2.0 [60] => Trident/5.0 [61] => SmartBotCrawler/1.0 [62] => ) The user agent is not in the allowed list.Array ( [0] => pingbot/2.0 [1] => Googlebot/2.1 [2] => ChatGPT-User/1.0 [3] => PerplexityBot/1.0 [4] => OAI-SearchBot/1.0 [5] => GPTBot/1.2 [6] => Perplexity-User/1.0 [7] => YandexBot/3.0 [8] => YandexFavicons/1.0 [9] => AdsBot-Google-Mobile [10] => AdsBot-Google [11] => Gemini-Deep-Research [12] => DuckAssistBot/1.1 [13] => DuckDuckBot/1.1 [14] => GoogleOther [15] => YandexRenderResourcesBot/1.0 [16] => YandexImages/3.0 [17] => DuckAssistBot/1.2 [18] => Baiduspider/2.0 [19] => Baiduspider-render/2.0 [20] => bingbot/2.0 [21] => YandexUserproxy [22] => Pingdom.com_bot_version_1.4_ [23] => GPTBot/1.3 [24] => PingdomPageSpeed/1.0 [25] => YandexMobileBot/3.0 [26] => ย OAI-SearchBot/1.3 [27] => ClaudeBot/1.0 [28] => OAI-SearchBot/1.3 [29] => ) The user agent is an allowed/known agent.
Blood Processing and Storage Equipment Market Size & Forecasts 2026-2035, By Segments (Product, End-use), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Thermo Fisher Scientific, Haemonetics, Beckman Coulter, Terumo BCT, Fresenius Kabi)
Market Size and Growth Outlook
Base Year Value (2025)
USD 52.71 Billion
CAGR (2026-2035)
7.5%
Forecast Year Value (2035)
USD 108.64 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035
Key Takeaways
- North America region achieved more than 39.9% market share in 2025, led by advanced healthcare infrastructure.
- Asia Pacific region will observe more than 9% CAGR through 2035, driven by growing blood bank investments.
- The devices segment contributed a 59.17% share to the blood processing and storage equipment market in 2025, propelled by automation enhancing efficiency in blood separation.
- The blood banks segment accounted for a 41.2% share of the market in 2025, due to centralized blood supply management in transfusion networks.
- Top companies in the blood processing and storage equipment market comprise Thermo Fisher Scientific (USA), Haemonetics (USA), Beckman Coulter (USA), Terumo BCT (USA), Fresenius Kabi (Germany), Grifols (Spain), Macopharma (France), Bio-Rad Laboratories (USA), Hettich (Germany), Helmer Scientific (USA).
Market Growth Drivers and Industry Trends
Increasing Blood Transfusions and Surgical Procedures
The rising frequency of blood transfusions and surgical procedures is a critical growth driver for the blood processing and storage equipment market. As healthcare systems worldwide adapt to growing patient needs, the demand for efficient blood management is accelerating. According to the World Health Organization, the need for safe blood transfusions is vital for surgical interventions, trauma care, and chronic disease management. This trend not only highlights the necessity for advanced processing and storage technologies but also creates opportunities for established manufacturers to innovate and expand their product offerings. New entrants can capitalize on this momentum by developing specialized equipment tailored to specific surgical applications, thus enhancing operational efficiencies in hospitals and clinics.
Blood Center Modernization and Automation
The ongoing modernization and automation of blood centers are reshaping the blood processing and storage equipment market. Regulatory bodies, such as the Food and Drug Administration, are advocating for enhanced safety and efficiency in blood collection and distribution, prompting centers to adopt state-of-the-art technologies. Automation reduces human error, streamlines operations, and ensures compliance with stringent regulations. Established players can leverage this shift by investing in next-generation automation solutions, while new entrants can introduce innovative systems that integrate seamlessly with existing infrastructures. As blood centers evolve, the focus on efficiency and safety will likely drive further investments in advanced processing technologies, setting a new standard for the industry.
Growth in Cell Therapy and Biobanking
The expanding fields of cell therapy and biobanking are significantly influencing the long-term storage needs within the blood processing and storage equipment market. As biopharmaceutical companies and research institutions increasingly explore cellular therapies, the demand for specialized storage solutions capable of preserving cellular integrity has surged. The National Institutes of Health emphasizes the importance of robust biobanking systems to support clinical research and therapeutic development. This trend presents strategic opportunities for both established firms to enhance their product portfolios with advanced cryopreservation technologies and for startups to develop innovative storage solutions tailored to emerging therapies. As the landscape of regenerative medicine continues to evolve, the integration of cutting-edge storage technologies will be paramount in meeting future demands.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing blood transfusions and surgical procedures boosting equipment demand | 1.20% | Short term (โค 2 yrs) | North America, Europe | High | Fast |
| Blood center modernization and automation driving medium-term replacements | 1.00% | Medium term (2โ5 yrs) | Europe, Asia Pacific | Medium | Moderate |
| Growth in cell therapy and biobanking expanding long-term storage needs | 0.80% | Long term (5+ yrs) | North America, Europe (spillover: Asia Pacific) | High | Moderate |
Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!
Regulatory Compliance Complexity
The blood processing and storage equipment market is significantly constrained by the intricate web of regulatory compliance requirements imposed by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These regulations mandate rigorous testing and validation processes to ensure safety and efficacy, which can lead to extended product development timelines and increased costs for manufacturers. For instance, the FDA's stringent premarket approval process can deter new entrants who may lack the resources to navigate these complexities, thereby limiting innovation and competition within the market. Established companies, while better equipped to handle such challenges, still face operational inefficiencies that arise from constantly evolving regulatory landscapes, which can slow down their ability to introduce new technologies and respond to market demands swiftly.
Technological Advancements Lag
Another critical restraint is the slower-than-expected adoption of advanced technologies such as automated blood processing systems and smart storage solutions. Despite the clear benefits these innovations offer in terms of efficiency and safety, market participants often exhibit hesitance due to high initial investment costs and the need for comprehensive training programs for personnel. For example, a report from the World Health Organization highlights that many healthcare facilities, particularly in developing regions, lack the infrastructure to support sophisticated equipment, leading to underutilization of available technologies. This lag in technological advancement not only hampers operational efficiency but also creates a competitive disadvantage for companies that fail to innovate. In the near to medium term, this restraint is likely to persist, as the market grapples with balancing the need for modernization against financial constraints and workforce readiness.
Regional Demand Dynamics
Largest Region
North America
39.9% Market Share in 2025
North America Market Statistics:
North America represented more than 39.9% of the global blood processing and storage equipment market in 2025, establishing itself as the largest and fastest-growing region. This dominance can be attributed to the advanced healthcare infrastructure prevalent across the region, which supports innovative technologies and high-quality standards in blood processing and storage. The increasing demand for efficient and reliable blood management systems, driven by a growing focus on patient safety and regulatory compliance, has further propelled the market. For instance, the American Red Cross has emphasized the need for state-of-the-art equipment to enhance blood safety and efficiency, reflecting broader trends in consumer preferences towards high-quality healthcare solutions. Additionally, the region's resilience in adapting to supply chain challenges and its commitment to sustainability initiatives are shaping a promising landscape for future investments in this sector.
The United States anchors the North American blood processing and storage equipment market, showcasing a robust framework for healthcare innovation. The country's regulatory environment, characterized by stringent guidelines from the Food and Drug Administration (FDA), has fostered a culture of excellence and safety in blood management practices. This has resulted in heightened consumer demand for advanced blood processing technologies, as hospitals and blood banks seek to comply with these regulations while improving operational efficiency. For example, the FDA's recent initiatives to streamline the approval process for new blood processing technologies have encouraged companies like Terumo Blood and Cell Technologies to accelerate product development, further enhancing competitive strategies within the market. The implications of these advancements position the United States as a critical player in driving regional growth opportunities in the blood processing and storage equipment market.
Asia Pacific Market Analysis:
Asia Pacific has emerged as the fastest-growing region in the blood processing and storage equipment market, registering a robust CAGR of 9%. This growth is primarily driven by increasing investments in blood bank infrastructure, which are essential for enhancing the efficiency and safety of blood collection, processing, and storage. Countries in this region are witnessing a significant shift in demand as healthcare systems prioritize the establishment of advanced blood banks to cater to rising patient needs and improve healthcare outcomes. The combination of rising healthcare expenditures, evolving consumer preferences towards quality medical services, and a strong emphasis on regulatory compliance is further propelling the market forward. Recent initiatives, such as those reported by the World Health Organization, highlight a growing commitment to improving blood safety and availability across the region, thus presenting substantial opportunities for market players.
Japan plays a pivotal role in the Asia Pacific blood processing and storage equipment market, characterized by its advanced healthcare infrastructure and high standards for medical practices. The country's focus on growing blood bank investments is reflected in its ongoing modernization efforts, which include the adoption of cutting-edge technologies for blood processing and storage. For instance, the Japanese Red Cross Society has been actively enhancing its blood donation and processing facilities, aligning with national health policies aimed at increasing blood safety and availability. This commitment is further supported by the Japanese governmentโs strategic investments in healthcare technology, fostering an environment conducive to innovation. As a result, Japan's emphasis on quality and efficiency in blood banking not only meets domestic needs but also sets a benchmark for other countries in the region, reinforcing Asia Pacific's leadership in the blood processing and storage equipment market.
China is another key player in the Asia Pacific blood processing and storage equipment market, driven by its rapid healthcare system expansion and increasing demand for blood products. The country's strategic focus on growing blood bank investments is evident in its national health initiatives aimed at enhancing blood donation rates and improving processing capabilities. The National Health Commission of China has launched several programs to upgrade blood donation centers and streamline blood supply chains, reflecting a significant shift towards modernizing blood banking practices. Additionally, the integration of digital technologies in healthcare is transforming operational efficiencies within blood banks, enabling better tracking and management of blood supplies. These developments not only cater to the growing consumer demand for safe and accessible blood products but also position China as a critical contributor to the overall growth of the Asia Pacific blood processing and storage equipment market.
Europe Market Trends:
Europe held a commanding share of the blood processing and storage equipment market, driven by a robust healthcare infrastructure and increasing investments in medical technologies. The region's significance is underscored by its commitment to enhancing healthcare outcomes, evidenced by initiatives from the European Commission aimed at improving blood safety and availability. Recent shifts in consumer preferences towards advanced, efficient solutions have catalyzed innovations in equipment design and functionality. Furthermore, the emphasis on sustainability in healthcare practices aligns with regulatory frameworks promoting eco-friendly technologies. As noted by the European Blood Alliance, the increasing demand for blood products, coupled with operational advancements in processing and storage techniques, positions Europe as a pivotal player in the global market, offering substantial opportunities for growth and innovation in the coming years.
Germany plays a crucial role in the blood processing and storage equipment market, characterized by its strong manufacturing capabilities and technological advancements. The country has witnessed a surge in demand for automated blood collection and storage systems, driven by a focus on enhancing operational efficiency and safety standards. The Federal Institute for Drugs and Medical Devices (BfArM) has implemented stringent regulations that ensure high-quality standards in blood processing, further stimulating market growth. Additionally, leading companies such as Fresenius Kabi are investing in research and development to introduce cutting-edge solutions tailored to the evolving needs of healthcare providers. This strategic focus on innovation and regulatory compliance positions Germany as a key contributor to the regional market dynamics, reinforcing Europe's attractiveness for investors seeking opportunities in the blood processing and storage equipment sector.
France also holds a significant position in the blood processing and storage equipment market, bolstered by a strong emphasis on public health initiatives and technological integration. The French government has prioritized the modernization of healthcare facilities, leading to increased adoption of state-of-the-art blood storage solutions. The French Blood Establishment (EFS) has reported a growing need for enhanced blood management systems, driven by demographic changes and rising patient needs. Companies like BioMรฉrieux are at the forefront of developing innovative diagnostic technologies that complement blood processing efforts, showcasing the intersection of technological advancement and healthcare requirements. By aligning with national health priorities and fostering innovation, France enhances its strategic role in the regional market, offering a fertile ground for growth and collaboration in the blood processing and storage equipment landscape.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Developing | Developing |
| Cost-Sensitive Region | Low | High | Medium | High | High |
| Regulatory Environment | Supportive | Neutral | Restrictive | Neutral | Neutral |
| Demand Drivers | Strong | Strong | Strong | Moderate | Moderate |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | High | Medium | High | Medium | Medium |
| New Entrants / Startups | Dense | Moderate | Dense | Sparse | Sparse |
| Macro Indicators | Strong | Strong | Stable | Stable | Stable |
No card data available for this language/report.
Segment Leadership and Growth Trends
Analysis by Product Segment
The blood processing and storage equipment market is predominantly led by the devices segment, which is projected to capture a commanding 59.17% share in 2025. This leadership can be attributed to the increasing demand for automation in blood separation processes, which enhances efficiency and accuracy. As healthcare providers increasingly prioritize operational efficiency and patient safety, the adoption of advanced blood processing devices has surged, reflecting a shift towards more streamlined and reliable blood management systems. Companies like Fresenius Kabi and Terumo Corporation are at the forefront, innovating to meet these demands. This segment presents significant strategic advantages for both established firms and new entrants, as the ongoing push for technological advancements and improved patient outcomes creates ample opportunities for growth. Looking ahead, the devices segment is expected to maintain its relevance due to continuous innovations in automation and digital transformation, ensuring that it remains integral to modern healthcare practices.
Analysis by End-use Segment
In the blood processing and storage equipment market, the blood banks segment is anticipated to hold a substantial 41.2% share in 2025. This prominence is driven by the increasing need for centralized blood supply management within transfusion networks, which enhances the efficiency and safety of blood distribution. The growing emphasis on regulatory compliance and quality assurance in blood collection and storage practices further solidifies the segment's leadership, as blood banks adopt advanced technologies to streamline operations. Organizations such as the American Association of Blood Banks (AABB) are actively promoting best practices, contributing to a more robust infrastructure in blood banking. This segment offers strategic opportunities for established players and emerging companies alike, particularly in developing innovative solutions that address the evolving needs of transfusion services. As the healthcare landscape continues to evolve, the blood banks segment is expected to remain crucial, driven by ongoing improvements in supply chain management and heightened public awareness of blood donation importance.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Product | Devices, Consumables | ||
| End-use | Blood banks, Diagnostic laboratories, Hospitals & clinics, Other end-users | ||
Read our Research ApproachCompetitive Landscape and Market Positioning
Company Profile
Business Overview Financial Highlights Product Landscape SWOT Analysis Recent Developments Company Heat Map Analysis
Key players in the blood processing and storage equipment market include Thermo Fisher Scientific, Haemonetics, Beckman Coulter, Terumo BCT, Fresenius Kabi, Grifols, Macopharma, Bio-Rad Laboratories, Hettich, and Helmer Scientific. These companies hold significant influence due to their extensive product portfolios and commitment to innovation. For instance, Thermo Fisher Scientific is recognized for its advanced technologies that enhance laboratory efficiency, while Haemonetics is notable for its specialization in blood component collection and processing. Each player leverages its unique strengths, such as Beckman Coulterโs focus on diagnostics and Terumo BCTโs expertise in blood management solutions, establishing a competitive edge that shapes market dynamics.
The competitive landscape of the blood processing and storage equipment market is marked by dynamic interactions among these leading entities, which engage in various strategic initiatives to enhance their market presence. Companies are increasingly forming alliances that facilitate the sharing of expertise and resources, thereby driving innovation. For example, collaborations to develop cutting-edge technologies are becoming more prevalent, enabling players like Grifols and Fresenius Kabi to expand their product offerings and improve operational efficiencies. Additionally, new product launches are frequently observed, reflecting a commitment to meet evolving customer needs and respond to competitive pressures, further solidifying their market positions.
Strategic / Actionable Recommendations for Regional Players
In North America, players could benefit from exploring partnerships with technology firms to integrate automation and artificial intelligence into their blood processing systems. This approach not only enhances operational efficiencies but also positions them favorably against emerging competitors. By focusing on high-growth niches such as point-of-care testing, companies can capture market share while addressing the increasing demand for rapid and accurate diagnostics.
For those in the Asia Pacific region, tapping into local research institutions for collaborative R&D initiatives can drive innovation and lead to the development of tailored solutions that cater to specific regional needs. Emphasizing the importance of regulatory compliance and quality assurance will also help in gaining trust and fostering long-term relationships with healthcare providers.
In Europe, responding to the competitive landscape may involve leveraging established distribution networks to expand reach, especially in underserved markets. Engaging in strategic collaborations with healthcare organizations can facilitate access to valuable insights and enhance product development efforts, ensuring that offerings remain aligned with market demands. Additionally, investing in sustainability initiatives could resonate well with European stakeholders, reinforcing brand reputation while addressing environmental concerns.
Frequently Asked Questions
How large is the blood processing and storage equipment market?
The market size of blood processing and storage equipment in 2026 is calculated to be USD 56.17 billion.
How is the blood processing and storage equipment industry projected to perform over the next decade?
Blood Processing and Storage Equipment Market size is estimated to increase from USD 52.71 billion in 2025 to USD 108.64 billion by 2035, supported by a CAGR exceeding 7.5% during 2026-2035.
In which region is the blood processing and storage equipment industry share the greatest?
North America region achieved more than 39.9% market share in 2025, led by advanced healthcare infrastructure.
Which geographical area is witnessing the highest growth rate in the blood processing and storage equipment sector?
Asia Pacific region will observe more than 9% CAGR through 2035, driven by growing blood bank investments.
Which is the largest sub-segment within the product segment for blood processing and storage equipment industry?
The devices segment contributed a 59.17% share to the blood processing and storage equipment market in 2025, propelled by automation enhancing efficiency in blood separation.
Why does blood banks sub-segment dominate the end-use segment of blood processing and storage equipment sector?
The blood banks segment accounted for a 41.2% share of the market in 2025, due to centralized blood supply management in transfusion networks.
Who holds a significant market share in the blood processing and storage equipment landscape?
Top companies in the blood processing and storage equipment market comprise Thermo Fisher Scientific (USA), Haemonetics (USA), Beckman Coulter (USA), Terumo BCT (USA), Fresenius Kabi (Germany), Grifols (Spain), Macopharma (France), Bio-Rad Laboratories (USA), Hettich (Germany), Helmer Scientific (USA).
Our Clients
Why Choose Us
Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.
Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.
Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.
Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.
Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.
Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.
Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.
Select Licence Type
